Stevanato Group (STVN) to Release Quarterly Earnings on Thursday

Stevanato Group (NYSE:STVN) will announce its earnings results before the market opens on Thursday, May 9th. Analysts expect the company to announce earnings of €0.12 ($0.13) per share for the quarter. Stevanato Group has set its FY 2024 guidance at 0.670-0.710 EPS and its FY24 guidance at €0.62-0.66 EPS.Parties that wish to register for the company’s conference call can do so using this link.

Stevanato Group (NYSE:STVN) last announced its earnings results on Thursday, March 7th. The company reported €0.18 ($0.19) EPS for the quarter, missing analysts’ consensus estimates of €0.19 ($0.20) by (€0.01) (($0.01)). The firm had revenue of €320.60 million for the quarter, compared to analyst estimates of €326.85 million. Stevanato Group had a net margin of 13.43% and a return on equity of 14.31%. Stevanato Group’s revenue was up 9.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.19 EPS. On average, analysts expect Stevanato Group to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Stevanato Group Stock Up 3.6 %

Shares of NYSE:STVN opened at €27.64 ($29.72) on Wednesday. The business’s 50 day moving average price is €29.51 and its 200-day moving average price is €29.08. Stevanato Group has a 1 year low of €23.00 ($24.73) and a 1 year high of €36.30 ($39.03). The company has a quick ratio of 1.06, a current ratio of 1.50 and a debt-to-equity ratio of 0.23.

Wall Street Analysts Forecast Growth

STVN has been the topic of several research reports. Morgan Stanley reissued an “equal weight” rating and issued a $30.00 price target on shares of Stevanato Group in a research note on Monday, April 22nd. Stephens reissued an “overweight” rating and issued a $38.00 target price on shares of Stevanato Group in a research note on Monday, March 25th. Finally, BNP Paribas assumed coverage on Stevanato Group in a research report on Monday, April 22nd. They issued an “outperform” rating for the company. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of €34.29 ($36.87).

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.